This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Lacticaseibacillus rhamnosus: NCBI 47715, [species]

Back to details

| ATCC 7469| CCUG 21452| CIP A157| DSM 20021| IFO 3425| JCM 1136| Lactobacillus casei rhamnosus| Lactobacillus casei subsp. rhamnosus| Lactobacillus casei subsp. rhamnosus Hansen 1968 (Approved Lists 1980)| Lactobacillus rhamnosus| Lactobacillus rhamnosus (Hansen 1968) Collins et al. 1989| Lactobacillus sp. NCIM 2587| Lactobacillus sp. W6| Lactobacillus sp. X9| LMG 6400| LMG:6400| NBRC 3425| NCAIM B.01147| NCCB 46033| NCDO 243| NCIMB 6375| NCTC 12953| NRRL B-442| VKM B-574

  1. Gut health: Lacticaseibacillus rhamnosus is known for its beneficial effects on gut health. It can help maintain a healthy balance of gut microbiota by competing with harmful bacteria for resources and adhering to the intestinal lining, thereby reducing the colonization of pathogenic bacteria. This can contribute to improved digestion, reduced gastrointestinal discomfort, and enhanced overall gut function.

  2. Immune modulation: Lacticaseibacillus rhamnosus has been shown to modulate the immune system, particularly in the gut-associated lymphoid tissue (GALT). It can stimulate the production of anti-inflammatory cytokines and regulatory immune cells, while also enhancing the activity of immune cells involved in defense against pathogens. This immune modulation may help reduce the risk of infections and allergic reactions, as well as support immune function in individuals with autoimmune conditions.

  3. Prevention and treatment of gastrointestinal disorders: Lacticaseibacillus rhamnosus supplementation has been studied for its potential to prevent and alleviate various gastrointestinal disorders, such as diarrhea, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and antibiotic-associated diarrhea. It may help restore gut microbial balance, reduce intestinal inflammation, strengthen the gut barrier function, and alleviate symptoms associated with these conditions.

  4. Women's health: Lacticaseibacillus rhamnosus has been investigated for its role in supporting women's health, particularly in preventing and treating urogenital infections such as bacterial vaginosis and urinary tract infections (UTIs). By colonizing the vaginal and urinary tracts, Lacticaseibacillus rhamnosus can inhibit the growth of pathogenic bacteria, maintain a lower pH environment, and prevent the adherence of pathogens to epithelial cells.

  5. Allergy prevention: Some studies suggest that early exposure to Lacticaseibacillus rhamnosus during infancy may help reduce the risk of developing allergic conditions, such as eczema, asthma, and food allergies. It is thought that the probiotic's immunomodulatory effects and its ability to strengthen the gut barrier may play a role in preventing allergic sensitization and promoting immune tolerance.

  6. Mental health: Emerging research indicates that the gut microbiota, including species like Lacticaseibacillus rhamnosus, may influence brain function and mental health through the gut-brain axis. While more studies are needed, preliminary evidence suggests that probiotics, including Lacticaseibacillus rhamnosus, may have potential benefits for mood regulation, stress management, and cognitive function.

Other Sources for more information:

Legend

Lacticaseibacillus rhamnosus impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.184502422809600830.5929657816886902Bifidobacterium breveParent Taxa
0.180414915084838870.4434501826763153Lacticaseibacillus paracaseiParent Taxa
0.119649820029735570.3588123917579651Staphylococcus epidermidisParent Taxa
0.11436280608177185-0.4009692370891571Campylobacter jejuniParent Taxa
0.10356251150369644-0.4049825370311737Campylobacter coliParent Taxa

Other bacteria of the same rank impacting Lacticaseibacillus rhamnosus

R2SlopeTax NameParent Chart
0.184502422809600830.3111518919467926Bifidobacterium breveParent Taxa
0.180414915084838870.40684372186660767Lacticaseibacillus paracaseiParent Taxa
0.119649820029735570.33346065878868103Staphylococcus epidermidisParent Taxa
0.11436280608177185-0.28521591424942017Campylobacter jejuniParent Taxa
0.10356251150369644-0.25572091341018677Campylobacter coliParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]